Copyright Reports & Markets. All rights reserved.

Global Lyme Disease Diagnostic Devices Market Research Report 2021

Buy now

1 Lyme Disease Diagnostic Devices Market Overview

  • 1.1 Product Overview and Scope of Lyme Disease Diagnostic Devices
  • 1.2 Lyme Disease Diagnostic Devices Segment by Type
    • 1.2.1 Global Lyme Disease Diagnostic Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Serological Test
    • 1.2.3 Urine Antigen Tests
    • 1.2.4 Lymphocytic Transformation Test
    • 1.2.5 Immunofluorescent Staining
    • 1.2.6 Nucleic Acid Test
  • 1.3 Lyme Disease Diagnostic Devices Segment by Application
    • 1.3.1 Lyme Disease Diagnostic Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Public/Private Laboratories
    • 1.3.4 Physician’s Office
  • 1.4 Global Lyme Disease Diagnostic Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Lyme Disease Diagnostic Devices Revenue 2016-2027
    • 1.4.2 Global Lyme Disease Diagnostic Devices Sales 2016-2027
    • 1.4.3 Lyme Disease Diagnostic Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Lyme Disease Diagnostic Devices Market Competition by Manufacturers

  • 2.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Lyme Disease Diagnostic Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Lyme Disease Diagnostic Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Lyme Disease Diagnostic Devices Market Competitive Situation and Trends
    • 2.5.1 Lyme Disease Diagnostic Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Lyme Disease Diagnostic Devices Players Market Share by Revenue
    • 2.5.3 Global Lyme Disease Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lyme Disease Diagnostic Devices Retrospective Market Scenario by Region

  • 3.1 Global Lyme Disease Diagnostic Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Lyme Disease Diagnostic Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Lyme Disease Diagnostic Devices Market Facts & Figures by Country
    • 3.3.1 North America Lyme Disease Diagnostic Devices Sales by Country
    • 3.3.2 North America Lyme Disease Diagnostic Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Lyme Disease Diagnostic Devices Market Facts & Figures by Country
    • 3.4.1 Europe Lyme Disease Diagnostic Devices Sales by Country
    • 3.4.2 Europe Lyme Disease Diagnostic Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Lyme Disease Diagnostic Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Lyme Disease Diagnostic Devices Sales by Region
    • 3.5.2 Asia Pacific Lyme Disease Diagnostic Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Lyme Disease Diagnostic Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Lyme Disease Diagnostic Devices Sales by Country
    • 3.6.2 Latin America Lyme Disease Diagnostic Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Lyme Disease Diagnostic Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Lyme Disease Diagnostic Devices Sales by Country
    • 3.7.2 Middle East and Africa Lyme Disease Diagnostic Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Lyme Disease Diagnostic Devices Historic Market Analysis by Type

  • 4.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Lyme Disease Diagnostic Devices Price by Type (2016-2021)

5 Global Lyme Disease Diagnostic Devices Historic Market Analysis by Application

  • 5.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Lyme Disease Diagnostic Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Abbott Laboratories
    • 6.1.1 Abbott Laboratories Corporation Information
    • 6.1.2 Abbott Laboratories Description and Business Overview
    • 6.1.3 Abbott Laboratories Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Abbott Laboratories Product Portfolio
    • 6.1.5 Abbott Laboratories Recent Developments/Updates
  • 6.2 T2 Biosystems, Inc.
    • 6.2.1 T2 Biosystems, Inc. Corporation Information
    • 6.2.2 T2 Biosystems, Inc. Description and Business Overview
    • 6.2.3 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 T2 Biosystems, Inc. Product Portfolio
    • 6.2.5 T2 Biosystems, Inc. Recent Developments/Updates
  • 6.3 Bio-Rad Laboratories
    • 6.3.1 Bio-Rad Laboratories Corporation Information
    • 6.3.2 Bio-Rad Laboratories Description and Business Overview
    • 6.3.3 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bio-Rad Laboratories Product Portfolio
    • 6.3.5 Bio-Rad Laboratories Recent Developments/Updates
  • 6.4 Alere Inc.
    • 6.4.1 Alere Inc. Corporation Information
    • 6.4.2 Alere Inc. Description and Business Overview
    • 6.4.3 Alere Inc. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Alere Inc. Product Portfolio
    • 6.4.5 Alere Inc. Recent Developments/Updates
  • 6.5 Roche Diagnostics
    • 6.5.1 Roche Diagnostics Corporation Information
    • 6.5.2 Roche Diagnostics Description and Business Overview
    • 6.5.3 Roche Diagnostics Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Roche Diagnostics Product Portfolio
    • 6.5.5 Roche Diagnostics Recent Developments/Updates
  • 6.6 Covance Inc.
    • 6.6.1 Covance Inc. Corporation Information
    • 6.6.2 Covance Inc. Description and Business Overview
    • 6.6.3 Covance Inc. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Covance Inc. Product Portfolio
    • 6.6.5 Covance Inc. Recent Developments/Updates
  • 6.7 Immunetics, Inc.
    • 6.6.1 Immunetics, Inc. Corporation Information
    • 6.6.2 Immunetics, Inc. Description and Business Overview
    • 6.6.3 Immunetics, Inc. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Immunetics, Inc. Product Portfolio
    • 6.7.5 Immunetics, Inc. Recent Developments/Updates
  • 6.8 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
    • 6.8.1 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Corporation Information
    • 6.8.2 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Description and Business Overview
    • 6.8.3 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Product Portfolio
    • 6.8.5 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Recent Developments/Updates
  • 6.9 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
    • 6.9.1 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Corporation Information
    • 6.9.2 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Description and Business Overview
    • 6.9.3 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Product Portfolio
    • 6.9.5 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Recent Developments/Updates
  • 6.10 Thermo Fisher Scientific(Affymetrix)
    • 6.10.1 Thermo Fisher Scientific(Affymetrix) Corporation Information
    • 6.10.2 Thermo Fisher Scientific(Affymetrix) Description and Business Overview
    • 6.10.3 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Thermo Fisher Scientific(Affymetrix) Product Portfolio
    • 6.10.5 Thermo Fisher Scientific(Affymetrix) Recent Developments/Updates
  • 6.11 Siemens AG
    • 6.11.1 Siemens AG Corporation Information
    • 6.11.2 Siemens AG Lyme Disease Diagnostic Devices Description and Business Overview
    • 6.11.3 Siemens AG Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Siemens AG Product Portfolio
    • 6.11.5 Siemens AG Recent Developments/Updates
  • 6.12 Baxter International Inc.
    • 6.12.1 Baxter International Inc. Corporation Information
    • 6.12.2 Baxter International Inc. Lyme Disease Diagnostic Devices Description and Business Overview
    • 6.12.3 Baxter International Inc. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Baxter International Inc. Product Portfolio
    • 6.12.5 Baxter International Inc. Recent Developments/Updates
  • 6.13 Fresenius Medical Care AG & Co.
    • 6.13.1 Fresenius Medical Care AG & Co. Corporation Information
    • 6.13.2 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Description and Business Overview
    • 6.13.3 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Fresenius Medical Care AG & Co. Product Portfolio
    • 6.13.5 Fresenius Medical Care AG & Co. Recent Developments/Updates

7 Lyme Disease Diagnostic Devices Manufacturing Cost Analysis

  • 7.1 Lyme Disease Diagnostic Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Lyme Disease Diagnostic Devices
  • 7.4 Lyme Disease Diagnostic Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Lyme Disease Diagnostic Devices Distributors List
  • 8.3 Lyme Disease Diagnostic Devices Customers

9 Lyme Disease Diagnostic Devices Market Dynamics

  • 9.1 Lyme Disease Diagnostic Devices Industry Trends
  • 9.2 Lyme Disease Diagnostic Devices Growth Drivers
  • 9.3 Lyme Disease Diagnostic Devices Market Challenges
  • 9.4 Lyme Disease Diagnostic Devices Market Restraints

10 Global Market Forecast

  • 10.1 Lyme Disease Diagnostic Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Lyme Disease Diagnostic Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Lyme Disease Diagnostic Devices by Type (2022-2027)
  • 10.2 Lyme Disease Diagnostic Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Lyme Disease Diagnostic Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Lyme Disease Diagnostic Devices by Application (2022-2027)
  • 10.3 Lyme Disease Diagnostic Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Lyme Disease Diagnostic Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Lyme Disease Diagnostic Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Serological Test
    Urine Antigen Tests
    Lymphocytic Transformation Test
    Immunofluorescent Staining
    Nucleic Acid Test

    Segment by Application
    Hospitals
    Public/Private Laboratories
    Physician’s Office

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Abbott Laboratories
    T2 Biosystems, Inc.
    Bio-Rad Laboratories
    Alere Inc.
    Roche Diagnostics
    Covance Inc.
    Immunetics, Inc.
    GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
    Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
    Thermo Fisher Scientific(Affymetrix)
    Siemens AG
    Baxter International Inc.
    Fresenius Medical Care AG & Co.

    Buy now